ProCE Banner Activity

Studies on Newer Antiretrovirals in Pregnancy: Time for a Paradigm Shift

Clinical Thought

We should move from protecting pregnant women from research to protecting them through research. That’s how we can safely provide newer antiretroviral therapy options for people with HIV during pregnancy

Released: November 02, 2022

Expiration: November 01, 2023

No longer available for credit.

Share

Faculty

Annette Haberl

Annette Haberl, MD

Physician
Head of HIV and Women, HIVCENTER Frankfurt
Department of Infectious Diseases
Hospital of the Johann Wolfgang Goethe-University
Frankfurt, Germany

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

ViiV Healthcare

Faculty Disclosure

Primary Author

Annette Haberl, MD

Physician
Head of HIV and Women, HIVCENTER Frankfurt
Department of Infectious Diseases
Hospital of the Johann Wolfgang Goethe-University
Frankfurt, Germany

Annette Haberl, MD: consultant/advisor/speaker: Gilead Sciences, Janssen-Cilag, Merck Sharpe and Dohme, ViiV Healthcare.